Intrinsic Value of S&P & Nasdaq Contact Us

Arvinas, Inc. ARVN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.80
+7.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Arvinas, Inc. (ARVN) has a negative trailing P/E of -9.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -11.11%.

Criteria proven by this page:

  • VALUE (78/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -11.11% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $11.80 (+7.3% upside) — modest upside expected.

Overall SharesGrow Score: 61/100 with 4/7 criteria passed.

SharesGrow 7-Criteria Score
61/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
64/100
→ Income
GROWTH
100/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — ARVN

Valuation Multiples
P/E (TTM)-9.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio1.68
P/S Ratio2.74
EV/EBITDA-6.0
Per Share Data
EPS (TTM)$-1.24
Book Value / Share$6.69
Revenue / Share$4.05
FCF / Share$-4.25
Yields & Fair Value
Earnings Yield-11.11%
Dividend Yield0.00%
Analyst Target$11.80 (+7.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -2.1 0.00 1.27 4.57 -
2017 -13.8 0.17 1,353.34 43.90 -
2018 -9.8 1.93 2.97 28.37 -
2019 -19.2 -0.43 5.97 31.48 -
2020 -28.1 -0.47 5.23 129.64 -
2021 -21.5 -0.81 5.25 76.62 -
2022 -6.4 -0.17 3.22 13.85 -
2023 -6.2 -0.25 3.46 29.10 -
2024 -6.9 0.12 2.45 5.23 -
2025 -9.5 0.18 1.77 2.93 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.80 $6.67M $-14.35M -215.2%
2017 $-1.16 $7.58M $-24.05M -317.3%
2018 $-4.40 $14.32M $-41.48M -289.6%
2019 $-1.89 $42.98M $-62.13M -144.6%
2020 $-2.83 $21.8M $-111.79M -512.7%
2021 $-3.66 $46.7M $-183.2M -392.3%
2022 $-5.11 $131.4M $-271.9M -206.9%
2023 $-6.62 $78.5M $-367.3M -467.9%
2024 $-2.77 $263.4M $-198.9M -75.5%
2025 $-1.28 $262.6M $-80.8M -30.8%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-3.32 $-4.21 – $-2.69 $93.17M $66.83M – $143.47M 12
2027 $-3.55 $-4.40 – $-2.88 $83.24M $31.74M – $144.29M 11
2028 $-2.14 $-3.75 – $2.83 $160.81M $160.81M – $160.81M 8
2029 $-1.87 $-3.84 – $-0.49 $208.6M $90.46M – $377.98M 6
2030 $-0.63 $-1.29 – $-0.17 $276.89M $120.07M – $501.7M 6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message